QUAIDE - Quality assessment of AI preclinical studies in diagnostic endoscopy.

Journal: Gut
PMID:

Abstract

Artificial intelligence (AI) holds significant potential for enhancing quality of gastrointestinal (GI) endoscopy, but the adoption of AI in clinical practice is hampered by the lack of rigorous standardisation and development methodology ensuring generalisability. The aim of the Quality Assessment of pre-clinical AI studies in Diagnostic Endoscopy (QUAIDE) Explanation and Checklist was to develop recommendations for standardised design and reporting of preclinical AI studies in GI endoscopy.The recommendations were developed based on a formal consensus approach with an international multidisciplinary panel of 32 experts among endoscopists and computer scientists. The Delphi methodology was employed to achieve consensus on statements, with a predetermined threshold of 80% agreement. A maximum three rounds of voting were permitted.Consensus was reached on 18 key recommendations, covering 6 key domains: data acquisition and annotation (6 statements), outcome reporting (3 statements), experimental setup and algorithm architecture (4 statements) and result presentation and interpretation (5 statements). QUAIDE provides recommendations on how to properly design (1. Methods, statements 1-14), present results (2. Results, statements 15-16) and integrate and interpret the obtained results (3. Discussion, statements 17-18).The QUAIDE framework offers practical guidance for authors, readers, editors and reviewers involved in AI preclinical studies in GI endoscopy, aiming at improving design and reporting, thereby promoting research standardisation and accelerating the translation of AI innovations into clinical practice.

Authors

  • Giulio Antonelli
    Gastroenterology Unit, Nuovo Regina Margherita Hospital, Rome, Italy.
  • Diogo Libanio
  • Albert Jeroen De Groof
    Department of Gastroenterology and Hepatology, Amsterdam UMC, Amsterdam, Netherlands.
  • Fons van der Sommen
    VCA Research Group, Eindhoven University of Technology, Eindhoven, The Netherlands.
  • Pietro Mascagni
    IHU Strasbourg, Strasbourg, France.
  • Pieter Sinonquel
    Department of Gastroenterology and Hepatology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium; Department of Translational Research in Gastrointestinal Diseases (TARGID), Catholic University Leuven, Herestraat 49, 3000, Leuven, Belgium. Electronic address: pieter.sinonquel@uzleuven.be.
  • Mohamed Abdelrahim
    Gastroenterology, Queen Alexandra Hospital, Portsmouth, UK.
  • Omer Ahmad
    University College London, London, UK.
  • Tyler Berzin
    Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Pradeep Bhandari
    Department of Gastroenterology, Queen Alexandra Hospital, Portsmouth, UK.
  • Michael Bretthauer
    Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, and Department of Transplantation Medicine Oslo University Hospital, Oslo, Norway.
  • Miguel Coimbra
  • Evelien Dekker
    Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam University Medical Centres, location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • Alanna Ebigbo
    Medizinische Klinik III, Klinikum Augsburg, Germany.
  • Tom Eelbode
    Department of Electrical Engineering (ESAT/PSI), KU Leuven, Kasteelpark Arenberg 10/2446, 3001, Leuven, Belgium; Medical Imaging Research Center (MIRC), UZ Leuven, Herestraat 49, 3000, Leuven, Belgium. Electronic address: tom.eelbode@kuleuven.be.
  • Leonardo Frazzoni
    Gastroenterology and Endoscopy Unit, Forlì-Cesena Hospitals, AUSL Romagna, Forlì, Italy.
  • Seth A Gross
    Division of Gastroenterology and Hepatology, NYU Langone Health, New York, New York, USA.
  • Ryu Ishihara
    Department of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.
  • Michal Filip Kaminski
    Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.
  • Helmut Messmann
    Medizinische Klinik III, Klinikum Augsburg, Germany.
  • Yuichi Mori
    Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, and Department of Transplantation Medicine Oslo University Hospital, Oslo, Norway; Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan. Electronic address: ibusiginjp@gmail.com.
  • Nicolas Padoy
    IHU Strasbourg, Strasbourg, France.
  • Sravanthi Parasa
    Department of Gastroenterology, Swedish Medical Center, Seattle, Washington, USA.
  • Nastazja Dagny Pilonis
    Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.
  • Francesco Renna
  • Alessandro Repici
    Digestive Endoscopy Unit, Division of Gastroenterology, Humanitas Clinical and Research Center IRCCS, Rozzano, 20089, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, MI, Italy.
  • Cem Simsek
    Department of Gastroenterology, Hacettepe University, Ankara, Turkey.
  • Marco Spadaccini
    Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
  • Raf Bisschops
    Department of Gastroenterology and Hepatology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium; Department of Translational Research in Gastrointestinal Diseases (TARGID), Catholic University Leuven, Herestraat 49, 3000, Leuven, Belgium. Electronic address: raf.bisschops@uzleuven.be.
  • Jacques J G H M Bergman
    Amsterdam UMC, Amsterdam, The Netherlands.
  • Cesare Hassan
    Gastroenterology Unit, Nuovo Regina Margherita Hospital, Rome, Italy.
  • Mario Dinis Ribeiro
    MEDCIDS, Faculty of Medicine, University of Porto, Porto, Portugal.